Search results
Aug 23, 2023 · People with polycythemia vera have a shorter-than-average life expectancy, but timely treatment can improve a person's outlook and prevent complications.
Apr 25, 2022 · Recent studies estimate the average life expectancy after diagnosis with polycythemia vera to be about 20 years. The average age of death is about 77. The most common cause of death is complications from blood clots (about 33%). Advancing cancer is the second most common cause (15%).
Dec 15, 2021 · Polycythemia vera can lower a person’s life expectancy due to complications, including blood clots that can affect the heart, brain, lungs, or other organs. These effects may cause lasting disability and can be fatal.
Feb 27, 2024 · With treatment, many people with Polycythemia vera (PV) will live at least 14 years after diagnosis. The younger you are, the better your outlook, though other factors can also affect life...
Feb 11, 2022 · Polycythemia vera is rare. It usually develops slowly, and you might have it for years without knowing. Often the condition is found during a blood test done for another reason. Without treatment, polycythemia vera can be life-threatening. But proper medical care can help ease signs, symptoms and complications of this disease.
Feb 11, 2022 · The most common treatment for polycythemia vera is having frequent blood withdrawals, using a needle in a vein (phlebotomy). It's the same procedure used for donating blood. This decreases your blood volume and reduces the number of excess blood cells.
Feb 27, 2024 · INTRODUCTION. Polycythemia vera (PV) is a BCR::ABL1 -negative myeloproliferative neoplasm characterized by excessive, clonal proliferation of erythroid cells.
Survival of patients with PV who receive contemporary treatment is typically decades-long, but symptoms (eg, pruritus, erythromelalgia, splenomegaly), complications (eg, venous or arterial thrombotic events), and hematologic transformation (eg, myelofibrosis, acute myeloid leukemia, myelodysplastic syndromes) cause significant morbidity and limi...
Nov 29, 2022 · Polycythemia vera (PV) is one of the myeloproliferative neoplasms (MPN) ( table 1 ), a group of hematopoietic stem cell-derived malignancies that are characterized by clonal proliferation of myeloid cells with variable degrees of morphologic maturity.
Jan 10, 2018 · Recently reported mature survival data have confirmed the favorable prognosis in polycythemia vera (PV), with an estimated median survival of 24 years, in patients younger than age 60 years...
